Project Grant R01AI177487
- This $649,815 project grant award from the U.S. Department of Agriculture's National Institute of Food and Agriculture (NIFA) under the Agriculture and Food Research Initiative (AFRI) program will support research to better understand the transmission, infection, and disease mechanisms of novel H5N1 highly pathogenic avian influenza (HPAI) viruses that have devastated the poultry industry since 2021. The award to the Regents of the University of Minnesota will enable comparative studies of three...
- Duke University, in partnership with North Carolina State University, will develop and evaluate a novel prime-boost vaccine regimen for highly pathogenic avian influenza (HPAI) in layer chickens under this $2.0 million Cooperative Agreement awarded by the Animal and Plant Health Inspection Service (APHIS) under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025). The project, which runs from February 2, 2026, through February 1, 2029, will combine two vaccine...
- This National Science Foundation Project Grant award of $199,999 provides funding for a research project titled "RAPID: Measuring Host Competence Across Wild Bird Species During Outbreaks of Highly Pathogenic Avian Influenza." The project will be carried out under the Biological Sciences (CFDA 47.074) federal grant program. The award supports research at the University of Massachusetts Boston to characterize the range of host competence of wild birds for highly pathogenic avian...
- The University of California, Davis was awarded a $999,374 Project Grant from the U.S. Department of Agriculture's Agriculture and Food Research Initiative (AFRI) program on March 15, 2025. The grant will support a 4-year research project to comprehensively evaluate the relationships between on-farm and off-farm risk factors for highly pathogenic avian influenza (HPAI) outbreaks in commercial poultry facilities across 30 states. The project aims to develop an agent-based model for predicting...
- This project grant, awarded by the U.S. Department of Agriculture's National Institute of Food and Agriculture (NIFA) under the Agriculture and Food Research Initiative (AFRI) program (CFDA 10.310), aims to investigate how certain strains of the avian influenza (bird flu) virus, particularly H5, H7, and H9, can adapt to infect cattle. The $649,992 grant, awarded on March 15, 2025, will fund research to understand the molecular mechanisms by which these viruses bind to and infect various cattle...
- Federal Project Grant Award Summary The University of North Carolina at Chapel Hill received a $496,076 Project Grant from the National Science Foundation's Division of Behavioral and Cognitive Sciences under the Social, Behavioral, and Economic Sciences program (CFDA 47.075) to investigate the geographic and ecological drivers of H5N1 avian influenza transmission and viral evolution in the United States. Running from October 1, 2025, through September 30, 2028, this project generates...
- The U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) awarded the University of Georgia Research Foundation, Inc. a $1,999,861 Cooperative Agreement under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025) on February 2, 2026, with a completion date of February 1, 2029. The award funds development of a two-pronged immunoprophylactic strategy to prevent and control highly pathogenic avian influenza (HPAI) in poultry. The project...
- Federal Cooperative Agreement Summary The Animal and Plant Health Inspection Service (APHIS) awarded a $803,771 Cooperative Agreement to the Trustees of Indiana University (April 1, 2026–May 3, 2029) under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025) to develop and validate an environmental surveillance platform for highly pathogenic avian influenza (HPAI) detection in Indiana. The project delivers two primary products: (1) a novel surveillance system that...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded University of Massachusetts Medical School $149,190 on December 17, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate hemagglutinin-mediated molecular mechanisms of avian influenza A virus (IAV) host tropism. The research project, scheduled for completion by June 30, 2027, addresses the pandemic threat posed by zoonotic transmission of avian...
- Federal Cooperative Agreement Summary The Animal and Plant Health Inspection Service (APHIS) awarded $1,999,873 to the University of Georgia Research Foundation on February 2, 2026, under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025) to develop the first U.S.-approved, mass-vaccination-ready modified live virus (MLV) vaccine against highly pathogenic avian influenza (HPAI). The project, scheduled for completion by February 1, 2029, leverages collaboration...
UNRAVELLING HIGHLY PATHOGENIC INFLUENZA VIRUS EMERGENCE - SUMMARY. HIGHLY PATHOGENIC AVIAN INFLUENZA VIRUSES (HPAIVS) ("BIRD FLU") DEVASTATE THE POULTRY INDUSTRY, THREATEN WILDLIFE, DAMAGE ECONOMIES, AND CONSTITUTE A PERMANENT PANDEMIC THREAT. HPAIVS EMERGE FROM LOW PATHOGENIC AVIAN INFLUENZA VIRUSES (LPAIVS) UPON TRANSMISSION FROM WILD WATERFOWL (E.G., DUCKS, GEESE, GULLS), THEIR MAIN RESERVOIR, TO TERRESTRIAL POULTRY (E.G., CHICKENS, TURKEYS). THE TRANSITION FROM LPAIV TO HPAIV RESULTS FROM THE INSERTION OF NUCLEOTIDES CODING FOR MULTIPLE BASIC AMINO ACIDS IN THE PROTEASE CLEAVAGE SITE OF THE VIRAL HEMAGGLUTININ (HA) GENE DURING REPLICATION OF THE VIRAL GENOME BY THE INFLUENZA VIRUS POLYMERASE. THIS CHANGE IN HA LEADS TO SYSTEMIC VIRUS DISSEMINATION CHARACTERIZED BY AN ENDOTHELIOTROPISM IN POULTRY WITH MORTALITY RATES UP TO 100%. IN CONTRAST, SYSTEMIC VIRUS DISSEMINATION, SEVERE DISEASE AND ENDOTHELIOTROPISM UPON HPAIV INFECTION ARE RARE OR ABSENT IN MOST SPECIES OF DUCK, WILD AND DOMESTIC. INTERESTINGLY, THE TRANSITION FROM LPAIV TO HPAIV HAS ONLY BEEN OBSERVED IN INFLUENZA VIRUSES OF THE H5 AND H7 SUBTYPES. MOREOVER, ALTHOUGH LPAIVS CIRCULATE EXTENSIVELY IN WILD WATERFOWL, THERE IS NO EVIDENCE THAT THEY CAN EVOLVE INTO HPAIVS IN THESE SPECIES. HPAIV EMERGENCE IS CURRENTLY UNPREDICTABLE BECAUSE THE MECHANISMS OF INITIAL EMERGENCE THROUGH NUCLEOTIDE INSERTION BY THE INFLUENZA VIRUS POLYMERASE, AND SUBSEQUENT PROCESS OF NATURAL SELECTION IN AVIAN HOSTS REMAIN POORLY UNDERSTOOD. TO UNDERSTAND THE MOLECULAR MECHANISM OF NUCLEOTIDE INSERTION, WE HAVE RECENTLY PREDICTED SUBTYPE-SPECIFIC RNA STEM-LOOP STRUCTURES AT THE HA CLEAVAGE SITE. HERE, WE HYPOTHESIZE THAT THE STEM OF THE STEM-LOOP STRUCTURE REFOLDS DURING VIRAL RNA REPLICATION LEADING TO THE TEMPLATE CLOSING ON ITSELF, TRAPPING THE POLYMERASE IN THE LOOP AND CAUSING IT TO STUTTER AND INSERT NUCLEOTIDES. ADDITIONALLY, WE HYPOTHESIZE THAT SPECIFIC RNA SEQUENCES PRESENT IN H5 AND H7 STEM-LOOPS DETERMINE WHY INSERTIONS ONLY OCCUR IN THESE SUBTYPES. TO TEST THESE HYPOTHESES, WE SUCCESSFULLY DEVELOPED IN VITRO POLYMERASE ASSAYS, INCLUDING SINGLE-MOLECULE ASSAYS, WITH WHICH NUCLEOTIDE INSERTIONS IN HA RNA CAN BE RELIABLY DETECTED WITH HIGH THROUGHPUT VIA CIRCULAR RESEQUENCING. SECONDLY, WE HYPOTHESIZE THAT INTRINSIC DIFFERENCES IN THE ABILITY OF HPAIV TO SPREAD SYSTEMICALLY IN POULTRY VERSUS WATERFOWL DETERMINE THE PROCESS OF NATURAL SELECTION OF HPAIVS FROM LPAIVS AND EXPLAIN THE HOST SPECIES-SPECIFICITY OF HPAIV EMERGENCE. MORE SPECIFICALLY, WE HYPOTHESIZE THAT HPAIV ARE SELECTED IN POULTRY AND NOT IN WATERFOWL BECAUSE OF THEIR ENDOTHELIOTROPISM IN POULTRY SUPPORTING THEIR SYSTEMIC DISSEMINATION. TO TEST THIS HYPOTHESIS, WE DESIGNED COMPETITION EXPERIMENTS BETWEEN LPAIV AND HPAIV TO STUDY THE NATURAL SELECTION AT THE HOST LEVEL IN CHICKENS (AS A MODEL FOR POULTRY) AND DUCKS (AS A MODEL FOR WATERFOWL) AND AT THE CELLULAR LEVEL USING NEWLY DEVELOPED IN VITRO TRANSWELL CO-CULTURE MODELS OF PRIMARY RESPIRATORY AND INTESTINAL EPITHELIAL AND ENDOTHELIAL CELLS OF CHICKENS AND DUCKS. INCREASED KNOWLEDGE ABOUT HPAIV EMERGENCE WILL FILL CRUCIAL KNOWLEDGE GAPS ON INFLUENZA AND MAY PROVIDE A POINT OF ACTION TO PREDICT - AND THUS POSSIBLY CONTROL - HPAIV EMERGENCE AND SUBSEQUENT OUTBREAKS THAT ARE THREATENING ANIMAL AND HUMAN HEALTH.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 2/20/26 | ||
| Not listed | $337.8k | 9/18/25 | ||
| Not listed | $337.8k | 9/18/25 | ||
| Not listed | $473.5k | 7/22/24 | ||
| Not listed | $384.7k | 7/31/23 |